Views:

Reminder: Email authentication to EMA systems - Timeline to convert your user

EMA has introduced email address authentication for EMA applications to improve security and usability of EMA applications by removing the need for users to remember their EMA username and password.
 

date: [30/01/2025]

 
 

Since the 30 September 2024: 

  • All new self-registered users are automatically set by default to email authentication. 
  • All users not converted are requested to opt-in before the 20 January 2025. 

On 20 January 2025 the EMA has initiated the conversion of all users that didn’t opt-in to the email authentication: 

  1. 20 January: Non regulatory users without specific application roles; 
  2. 3 February: Non regulatory users with application roles; 
  3. 3 March: Regulatory users (European medicines regulatory network). 
  4. 31 March: all users are converted. 

 

How to opt in 

If not yet done, the users are requested to opt-in at the earliest convenience to email authentication in EMA Account Management by following the enclosed detailed instructions. 

Once converted to email authentication, users can use email address to authenticate into EMA systems. In this way, as showed in the figure below, and depending on the user domain, they will either be redirected to their authentication page or will receive an email with an authentication code. 

A screenshot of a computer screen<br><br>Description automatically generated 

 

Useful links 

 

Contact 

If you cannot find the support you need in the guidance documents, please contact the EMA Service Desk. 
Alternatively, if you are unable to access the EMA Service Desk, please send an email directly to servicenow@ema.europa.eu indicating your name, surname and your unique username and we will help you with your request.